Event : FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program http://www.rsc.org/events/detail/5268/FDA%20Clinical%20Trial%20Auditing%20and%20the%20due%20diligence%20Companies%20should%20conduct%20as%20part%20of%20their%20monitoring%20program This is a feed for event : FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program Thu, 11 Sep 2014 13:13:13 +0100 5268 5268 http://www.rsc.org/events/detail/5268/FDA%20Clinical%20Trial%20Auditing%20and%20the%20due%20diligence%20Companies%20should%20conduct%20as%20part%20of%20their%20monitoring%20program FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program Event dates: 24 February 2011<br/>Event summary: This Clinical Trial Auditing webinar will help you in preparing your site for a GCP audit. Attendees will learn how to identify and remedy gaps in their monitoring system and prepare for regulatory <br/>Event Venue: Online Event, Palo Alto, 94303, United States Thu, 11 Sep 2014 13:13:13 +0100 2014-09-11T13:13:13+01:00